Details
FUSYS Indication
The treatment of such diseases in adults such as:
- Cryptococcal meningitis;
- Coccidioidomycosis;
- Invasive candidiasis;
- Mucosal candidiasis including oropharyngeal candidiasis and esophageal candidiasis; kandyduriya, chronic candidiasis of the skin and mucous membranes;
- Chronic atrophic candidiasis (candidiasis caused by dentures) after failure of local dental hygiene products; - Vaginal candidiasis, acute or recurrent when local therapy is not feasible;
- Candida balanitis when local therapy is not feasible;
- Ringworm, including athlete's foot, athlete's smooth skin, inguinal dermatomycosis; colorful lichen and Candida skin infections when systemic therapy is inappropriate;
- Dermatofitnyy onychomycosis, as with other products is inappropriate.
Prevention of diseases in adults such as:
- Relapse of cryptococcal meningitis in patients with high risk of development;
- Oropharyngeal candidiasis relapse or esophagus in HIV-infected patients with a high risk of development;
- Reduce recurrence of vaginal candidiasis (4 or more cases per year);
- Prevention of Candida infections in patients with prolonged neutropenia (such as patients with malignant blood diseases that patients receive chemotherapy or transplantation of hematopoietic stem cells).
